GoGoVax Study
The GoGoVax Study is a world-first study being conducted now, using a licensed meningococcal B vaccine to prove if the vaccine can also prevent gonorrhoea.
The GoGoVax Study is a world-first study being conducted now, using a licensed meningococcal B vaccine to prove if the vaccine can also prevent gonorrhoea.
Garvan Institute; The Kinghorn Cancer Centre; Cancer Council NSW; Positive Life NSW: St Vincent’s Centre for Applied Medical Research Coronavirus Outcomes Registries in Immunocompromised Individuals Australia (CORIA) is an observation cohort study of immunosuppressed [...]
Kirby Institute, UNSW Sydney; Positive Life NSW The Cohort of austraLian hIv wOmen (CLIO) study is a pilot study to address some of the gaps in knowledge in research undertaken on women living with [...]
The Kirby Institute, UNSW Sydney; NSW Health; Centre for Social Research in Health, UNSW Sydney The Bloodborne viruses and sexually transmissible infection Research, Intervention and Strategic Evaluation (BRISE) program is a NSW Government–funded, university-based [...]
Kirby Institute, UNSW Sydney; Peter MacCallum Cancer Centre, Victoria; Positive Life NSW The Age-Related Clonal Haematopoiesis in an HIV Evaluation (ARCHIVE) study looks at genomic factors associated with ageing and the development of comorbidities [...]